Variation in readmission and mortality following hospitalisation with a diagnosis of heart failure: prospective cohort study using linked data by Rosemary J. Korda et al.
Korda et al. BMC Health Services Research  (2017) 17:220 
DOI 10.1186/s12913-017-2152-0RESEARCH ARTICLE Open AccessVariation in readmission and mortality
following hospitalisation with a diagnosis
of heart failure: prospective cohort study
using linked data
Rosemary J. Korda1*, Wei Du1, Cathy Day1, Karen Page2, Peter S. Macdonald3 and Emily Banks1,4Abstract
Background: Hospitalisation for heart failure is common and post-discharge outcomes, including readmission and
mortality, are often poor and are poorly understood. The purpose of this study was to examine patient- and
hospital-level variation in the risk of 30-day unplanned readmission and mortality following discharge from hospital
with a diagnosis of heart failure.
Methods: Prospective cohort study using data from the Sax Institute’s 45 and Up Study, linking baseline
survey (Jan 2006-April 2009) to hospital and mortality data (to Dec 2011). Primary outcomes in those
admitted to hospital with heart failure included unplanned readmission, mortality and combined unplanned
readmission/mortality, within 30 days of discharge. Multilevel models quantified the variation in outcomes
between hospitals and examined associations with patient- and hospital-level characteristics.
Results: There were 5074 participants with a heart failure admission discharged from 251 hospitals; 1052
(21%) had unplanned readmissions, 186 (3.7%) died, and 1146 (23%) had either/both outcomes within
30 days of discharge. Crude outcomes varied across hospitals, but between-hospital variation explained little
of the total variation in outcomes (intraclass correlation coefficients (ICC) after inclusion of patient factors:
30-day unplanned readmission ICC = 0.0125 (p = 0.24); death ICC = 0.0000 (p > 0.99); unplanned readmission/
death ICC = 0.0266 (p = 0.07)). Patient characteristics associated with a higher risk of unplanned readmission
included: being male (male vs female, adjusted odds ratio (aOR) = 1.18, 95% CI: 1.00–1.37); prior hospitalisation
for cardiovascular disease (aOR = 1.44, 1.08–1.91) and for anemia (aOR = 1.36, 1.14–1.63); comorbidities at admission
(severe vs none: aOR = 1.26, 1.03–1.54); lower body-mass-index (obese vs normal weight: aOR = 0.77, 0.63–0.94); and lower
social interaction scores. Similarly, risk of 30-day mortality was associated with patient- rather than hospital-level factors, in
particular age (≥85y vs 45–< 75y: aOR = 3.23, 1.93–5.41) and comorbidity (severe vs none: aOR = 2.68, 1.82–3.94).
Conclusions: The issue of high readmission and mortality rates in people with heart failure appear to be system-wide,
with the variation in these outcomes essentially attributable to variation between patients rather than hospitals. The
findings suggest that there are limitations in using these outcomes as hospital performance measures in this patient
population and support the need for patient-centred strategies to optimise heart failure management and outcomes.
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Heart failure is a major health problem in high income
countries; in Australia an estimated 2.8% of the total
population aged 45 years and older are affected [1].
Although treatment for heart failure has improved and
both mortality and hospital rates have been declining
[2–5], the annual rate of hospitalisation for this condi-
tion remains relatively high; it was the primary reason
for admission to hospital in over 47 thousand admissions
in Australia in 2013–14 [6]. Of particular concern is the
high hospital readmission rate, with around one in every
four or five patients admitted to hospital with a heart
failure diagnosis being readmitted within one-month of
discharge—three-quarters within one year [5, 7]. Morta-
lity rates following admission to hospital for heart failure
are also high, although possibly declining over time [4],
with around one in ten dying within one month of
admission for heart failure and one quarter within a year
[4, 5]. Similar heart failure prevalences and high
readmission and mortality rates are observed in other
countries [8–13].
Rates of death and readmission—particularly unplanned
returns to hospital—within one month of hospital dis-
charge are used as hospital performance measures, both
nationally and internationally [6, 14–16]. These measures
can reflect the quality of care provided in hospital and
access to appropriate follow-up after discharge, thus pro-
viding an indication that patient care could be improved
and/or that more efficient use could be made of available
resources [14]. However, it is recognised that not all
readmissions and deaths are avoidable, with the risks also
relating to individual patient characteristics such as age
and comorbidity. Moreover, to understand hospital
variation in heart failure outcomes requires a quantitative
understanding of the contributions of variation at both
the hospital and patient level. A recent Australian report
has investigated the distribution of these performance
measures according to hospital, risk adjusting for patient
age, sex and comorbidities, with an emphasis on those
hospitals which are “outliers” [14]; and other Australian
studies have examined patient-level risk factors derived
from linked hospital records [5, 7, 11, 17, 18]. However,
there remains a lack of large-scale quantitative data that
quantify both patient and hospital-level variation in post-
discharge heart failure outcomes, and associations with
patient characteristics.
The purpose of this study was to use linked population-
based survey, hospital and death data to examine patient-
and hospital-level variation in the risk of 30-day unplanned
readmission and 30-day mortality among those aged
45 years and over discharged from hospital with a diagnosis
of heart failure. Specifically, using multilevel modelling, the
study aimed to: quantify the variation in outcomes—un-
planned readmissions and mortality—across hospitals;examine the extent to which selected patient, heart failure
admission and hospital characteristics explain this variation;
and quantify the strength of association between the out-
comes and patient and hospital characteristics.
Methods
Data sources and study population
We used data from the Sax Institute’s 45 and Up Study, a
prospective cohort study involving 267,153 men and
women aged 45 years and over from New South Wales
(NSW). Participants in the Study were randomly sampled
from the database of Medicare Australia, with over-
sampling, by a factor of two, of individuals aged 80 years
and over and residents in rural areas. Around 10% of the
entire NSW population aged 45 years and over was in-
cluded in the cohort [19]. Participants joined the study by
completing a baseline questionnaire, distributed between
1 January 2006 and 31 December 2008, and provided
signed consent for linkage of their information to a range
of health-related databases. The 45 and Up Study is
described in detail elsewhere [19], and questionnaires can
be viewed at https://www.saxinstitute.org.au/our-work/45-
up-study/questionnaires.
Questionnaire data from study participants have been
linked probabilistically to the NSW Admitted Patient Data
Collection (APDC) and the NSW Register of Births,
Deaths and Marriages (RBDM) by the Centre for Health
Record Linkage. The APDC is a census of all public and
private hospital admissions in NSW. The linked data for
this study contain details of admissions for participants
from 1 January 2000 to 31 December 2011, including
dates of admission and discharge, the primary reason for
admission and up to 54 additional clinical diagnoses coded
using the International Classification of Diseases 10th re-
vision (ICD-10) Australian Modification [20], whether the
admission was planned or unplanned, discharge status
and hospital type. Linked death data were also available
until December 2011. Death registrations capture all
deaths in NSW; date, but not cause, of death information
was available for this study.
Study sample
The study sample comprised 45 and Up Study partici-
pants with linked data and who had at least one admis-
sion with a heart failure diagnosis recorded following
entry into the Study (ICD-10 codes: I50, I11.0, I13.0,
I13.2). We included those with heart failure recorded as
either a primary diagnosis or as an additional diagnosis
in any of the 54 additional diagnosis fields. The first
admission following entry into the study in which a
heart failure diagnosis was recorded is hereafter referred
to as the index admission. We excluded those who died
before being discharged from hospital and those who
did not have at least 30 days of follow-up time (i.e.
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after 1 Dec 2011). We also excluded those whose first
readmission to hospital within the 30-day follow-up was
a planned overnight readmission or was one of multiple
planned admissions (overnight or same day); these ex-
clusion criteria were applied as these planned admissions
are likely to affect the risk of an unplanned admission.
See Fig. 1 for a flow chart of sample selection.
Participants were followed for 30 days from the date of
discharge from their index admission. Over the relatively
short follow-up period, a small but unknown number of
participants are likely to have moved out of NSW; among
those continuing to reside in NSW, follow-up for hospita-
lisations is considered to be ~98% complete [21]. Quality
assurance data on the data linkage show false positive and
negative rates of <0.5 and <0.1%, respectively.
Outcomes: readmissions and deaths
The main outcomes were (a) 30-day unplanned readmis-
sion: unplanned readmission (emergency admission type)
within 30 days of discharge of the index admission for any
cause; and (b) 30-day mortality: death from any cause
within 30 days of discharge of the index admission; and
(c) due to the likelihood of competing risks, we also in-
cluded a combined readmission or mortality outcome, 30-
day unplanned readmission/mortality.Final sample
(n=5,074)
Participants with index admission for 
heart failure and discharged alive
(n=5,696)
Participants with index admission for 
heart failure
(n=6,381)
Participants with linked data 
(n=266,757)
Total 45 and Up Cohort 
(n=267,153)
Fig. 1 Study population flow chart of sample exclusionsThe linked APDC records were used to identify the
index admission, discharge status (dead or alive),
discharge hospital type and unplanned readmissions.
The linked RBDM records were used to identify deaths
post discharge. The date of discharge was taken as time
zero for time-to-event calculations. Where an episode of
care ended with transfers (determined from admission
and separation dates of consecutive admissions), we
treated all consecutive episodes as a nested care, and
thus, the date of discharge was the date of discharge
from the last hospital in which the nested care ended;
similarly, hospital characteristics were based on the
hospital from which the patient was discharged.
Exposures: patient, index admission and hospital
characteristics
Sociodemographic information and most of the baseline
health information was self-reported on the baseline
questionnaire (apart from area of residence, which was
derived from postcodes obtained from Medicare data).
Other information on health status, including previous
hospital admission diagnoses, and information on index
admission and hospital characteristics, was obtained
from the APDC records.
Sociodemographic variables, self-reported on the baseline
questionnaire, included: age, calculated as age at admissionExclude those who were discharged 
after 1 Dec 2011 (n=126) and those 
whose first readmission to hospital 
was a planned overnight readmission 
or one of multiple planned admissions 
(n=496)
Exclude those who died before 
discharge
(n=685)
Exclude those for whom linked data 
was not available at time of study 
(n=396)
Exclude those without heart failure 
hospitalisation post baseline
(n=260,376)
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male); area of residence (major cities, inner regional, more
remote, based on the Accessibility/ Remoteness Index of
Australia Plus [22] score associated with the postcode of
residence); marital status (single, defacto/married); language
other than English spoken at home (yes, no); education
(highest qualification categorised as no school certificate,
school/trade certificate or diploma, tertiary degree); income
(pre-tax annual household annual household income from
all sources including benefits, pensions and superannuation,
categorised as < $20,000, $20,000–39,999, $40,000–69,999,
≥$70,000) and private health insurance (yes, no).
Baseline health variables self-reported on the question-
naire included: smoking (never, past, current); alcohol
intake (0, 1– < 15, ≥15 drinks per week); body mass
index (BMI) (underweight (<18 kg/m2), normal weight
(18– < 25 kg/m2), overweight (25– < 30 kg/m2), obese
(30– < 50 kg/m2)); and excellent memory (yes, no). Heart
disease (yes, no) and diabetes (yes, no) was determined
by asking the participant if a doctor had ever told them
that they had that condition. Physical functioning was
assessed using the Medical Outcomes Study-Physical
Functioning [23]. The scale assesses functional scale cap-
acity by inquiring about an individual’s ability to perform
a range of moderate and vigorous physical tasks as well
as everyday activities. The total PF-10 score ranges from
0 to 100 and was categorised as severe physical func-
tional limitation (<75) or not (≥75). Psychological dis-
tress was determined using the Kessler Psychological
Distress Scale (K10) [24]. All items on the K10 begin
with the phrase ‘during the past 4 weeks, about how
often did you feel (…)’ followed by the description of an
emotional state, such as: ‘tired out for no good reason?’
All answer options were based on a 5-point scale (‘none
of the time’ (1), through to, ‘all of the time’ (5)). The K10
score has a range from 10 to 50 and was categorised as
low (<16), medium (16– < 22), high (22–30) and very
high (≥30). We also calculated a social interaction score,
based on items similar to those used in the social inter-
action subscale score of the Duke Social Support Index
[25, 26]. This subscale has four items, with the total sub-
scale score ranging from 4 to 12, with higher scores indi-
cating more social interaction.
Baseline health variables derived from APDC records
included prior hospitalisation in the 6 years prior to
baseline for each of the following conditions: heart fail-
ure, other major cardiovascular disease (I11-I13 [excl.
I11.0, I13.0 and I13.2]; I20-I28, I34-36, I42, I44-I49, I51,
I61-I67, I69, I70-I77, I80, G45, G46) [27], renal disease
(I12.0, I13.1, N03.2 N03.7, N05.2-N05.7, N18, N19,
N25.0, Z49.0, Z94.0, Z99.2), anaemia (D50-D53, D55-59-
D66), atrial fibrillation (I48) and dementia (F00-F03,
G30, G31.0, G31.1, G31.8), as identified in any of the 55
diagnosis fields. The time frame of pre-enrolmenthospitalisation history was set to 6 years as this was the
maximum retrospective follow-up available for the
whole study population.
Index admission characteristics, derived from APDC re-
cords, included heart failure primary diagnosis, classified
as either yes, i.e. diagnosis of heart failure recorded in the
primary diagnosis field, or no, i.e. heart failure diagnosis
recorded only in one of the 54 secondary diagnosis fields;
whether unplanned admission or not (based on urgency
of admission status); comorbidity using the Charlson
index (i.e., sum of death propensity scores assigned to 16
conditions including pulmonary disease, diabetes, myocar-
dial infarction, peripheral vascular disease, cerebral
vascular disease, cancer, and liver disease) [28] for the
index admission (categorised as none: total score of 0;
mild-moderate: total score of 1 or 2; or severe: total score
≥2); length of stay, calculated as separation date minus
admission date, plus one day for same day admissions
(categorised as 1, 2–6, ≥7); prior hospitalisation days, cal-
culated as the number of days spent in hospital in the
12 months prior to the index admission; and prior
hospitalisation-admissions, calculated as the number of
admissions in the 12 months prior to the index admission.
Hospital characteristics included hospital type, based on
the Australian Institute of Health and Welfare peer group
classification system, which categorises hospitals captured
in the APDC using type and nature of the services pro-
vided in addition to casemix-adjusted separations and
geographic locations [29]; we further categorised peer
groups as principal referral (classification A), major city
(classification B), medium district (classification C), small
community (classification D), private hospital group, or
other (classifications E, F, G). We also considered charac-
terising hospitals in relation to remoteness and hospital
size; however these characteristics are essentially captured
in the peer group classification. In addition, we classified
hospitals according to whether they had a dedicated heart
failure service, using information compiled in the Heart
Foundation’s Directory of NSW/ACT Cardiovascular
Health Services (Version 15, Jan 2014).
Statistical analysis
For descriptive data, numbers and proportions (risks) are
presented, where appropriate. We graphed crude risks of
readmission and death (with 95% confidence intervals) in
increasing order by hospital, excluding hospitals with
fewer than 5 index admissions. To allow for the small
number of index admissions in some hospitals, we
used the Agresti-Coull correction [30]. We also used
Kaplan-Meier curves to present the elapsed time from
date of discharge until the occurrence of death or
first readmission graphically by hospital groups and
nonparametric log-rank tests to detect differences
between hospital groups.
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regression models, with patients (first level) nested in hos-
pitals (second level). These models account for possible
patient clustering within hospitals and enable hospital
variation in the risk of readmission or death to be quanti-
fied (random effects), as well as estimation of the strength
of the associations between these outcomes and patient
and hospital characteristics (fixed effects), after accounting
for hospital-level variation.
To examine the associations between the outcomes and
all of the patient, admission and hospital characteristics,
we first ran age and sex adjusted analyses. These analyses
were used to guide which characteristics to include in the
final multilevel models. We included the following vari-
ables in the full-risk-adjusted model: age, sex, smoking
status, and previous hospitalisation for heart failure, other
major cardiovascular disease, dementia, anaemia and renal
disease; and of the other individual covariates, we retained
those with a p-value less than 0.25 in the age and sex
adjusted analyses and/or causing a change in the effect
size of 10% or more. To reduce the impact of collinearity,
we omitted length of stay and used the Charlson Index as
the single proxy of index case severity. We used Type III
tests of fixed effects (between and within method) for
modelled predictors.
We ran a series of multilevel models for each of the
outcomes, using five model specifications. The first was
a null model (i.e. it did not include any patient or
hospital-level exposure variables), with only random
intercepts to examine if there was significant variation in
readmission or mortality across hospitals (Model 1). In
subsequent models we sequentially added covariates to
the previous model: Model 2, age and sex; Model 3,
additional patient sociodemographic variables; Model 4,
patient health and index admission characteristics; and
in Model 5, hospital level variables. Missing values for
categorical covariates were included in the models as
separate categories, except for the continuous Duke
Social Support Index, where missing values were
assigned the median value (with this having little impact
on the regression coefficient point estimate while main-
taining the sample size as a conservative substitute for
imputation).
Hospital-level variation in outcomes was estimated in
terms of variance, and a range of statistical terms were
used to report between-hospital variation (random ef-
fects), including: the intraclass correlation coefficient
(ICC), used an estimate of the proportion of overall vari-
ation in outcomes explained by variation between hospi-
tals; the proportional change in variance, which is the
percentage change in the variance with the addition of
variables into the model; and the median odds ratio, which
quantifies hospital variance in terms of odds ratios, de-
scribing the median increased individual risk associatedwith moving to a hospital with higher risk [31, 32]. We es-
timated the associations between patient, admission and
hospital characteristics and study outcomes (fixed effects)
in terms of odds ratios (ORs), with 95% confidence inter-
vals (CI). P-values less than 0.05 were considered statisti-
cally significant.
We also ran a series of sensitivity analyses. We exam-
ined the effects of excluding index hospitalisations for
patients with previous hospitalisations for heart failure,
and of including only index hospitalisations where heart
failure was the primary diagnosis. We considered
restricting readmissions to heart failure admissions only;
however there was an insufficient number of cases to
proceed with these analyses.
The study adhered to STROBE guidelines. We used
SAS 9.4 package (SAS Institute, Cary, NC) to perform
all data analyses.Results
Sample description
At the time of this study, linkages could be made for
266,757/267,153 (99% of participants) in the 45 and Up
Study cohort. Among these participants, a total of 6381
index admissions for heart failure were identified
(>99% with ICD-10 code I50). Compared to the other
cohort members, those with a heart failure admission
were older (9% vs 45% aged ≥85 years, respectively),
were more likely to be male (48% vs 58%) and had
poorer health at baseline (self-reported poor health:
2.6% vs 12%).
After excluding 685 patients (11%) who died before
discharge and other exclusions (see Fig. 1), there were
5074 patients/index admissions in the final sample. Of
these, 1973 (39%) were for a primary diagnosis of heart
failure; 4180 admissions (82%) of total index admissions
were unplanned. The majority of patients (58%) were
male, and age at index admission ranged from 48 to
>100 years, median 82 years (IQR: 12). In terms of
baseline health, almost a quarter (23%) had at least one
hospital admission with a diagnosis of heart failure
recorded in the 6 years prior to baseline, and a large
proportion (92%) had at least one prior admission for
another major cardiovascular disease. Of those with
known physical functioning scores, more than two-
thirds (70%) were classified as having severe limitations
at baseline. At the time of the index admission, 28%
of patients had Charlson Index scores indicating mod-
erate comorbidity and 15% severe comorbidity. Pa-
tients were discharged from 251 different hospitals,
with half (49%) of all discharges from principal refer-
ral hospitals. Further sample characteristics are shown
in Table 1 and additional hospital characteristics are in
Additional file 1: Table S1.
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Overall, 21% (1052/5074) of the patients with heart failure
discharged from hospital had unplanned readmissions,
3.7% (n = 186) died within 30 days of discharge and 23%
(n= 1146) had either or both outcomes (readmission/death).
Between-hospital variation in risk of readmission and/or
death
A number of hospitals had no readmissions (74/251, 30%)
or deaths (166/251, 66%) within 30 days of discharge in
the period of interest. The crude risks, reported for the
157 hospitals (63%) that had at least 5 index admissions
(accounting for 96% of the total admissions), ranged
from 0 to 57% (median = 20; IQR = 11) for 30-day un-
planned readmission; from 0 to 21% (median = 1.1;
IQR = 5.3) for 30-day mortality and from 0 to 60%
(median = 22; IQR = 14) for 30-day readmission/mor-
tality (see Fig. 2).
Time to unplanned readmission and to death according
to discharge hospital type is shown in Fig. 3. The probabil-
ity of unplanned readmission (log-rank test, p < 0.001),
but not survival (p = 0.061), differed significantly across
hospital peer groups. Patients discharged from public
hospitals had a higher probability of unplanned readmis-
sion, compared with those admitted to private hospitals
(p < 0.001); among public hospitals, there was no
significant difference in the probability of unplanned read-
missions between the principal referral hospitals and other
hospital types (p = 0.48).
Multilevel modelling (Fig. 4; and Table 2–30-day
unplanned readmission; Table 3–30-day mortality; and
Additional file 2: Table S2–30-day unplanned readmis-
sion/mortality) showed the proportion of overall variation
in outcomes explained by variation between hospitals
(Model 1) was not statistically significant for unplanned
readmission (ICC = .0205, p = 0.12) or mortality (ICC =
0.0000), while the between-hospital variation in the com-
bined readmission/mortality outcome was marginally sig-
nificant in the null model, explaining 3.0% of the total
variance in outcomes (p = 0.04). After adjusting for age and
sex (Model 2), there was little change in the between-
hospital hospital variation in any of the outcomes. There
was a gradual reduction in the proportion of variance ex-
plained at the hospital level in unplanned readmissions and
unplanned readmission/mortality after adjusting for add-
itional sociodemographic variables (Model 3) and patient
health and admission characteristics (Model 4), with
between-hospital variation not statistically significant in
these models.
Associations between patient, admission and hospital
characteristics and risk of readmission and death
Age-sex adjusted associations between the outcomes and
all of the patient, admission and hospital characteristicsconsidered for the multilevel models are shown in Add-
itional file 3: Table S3. The following characteristics were
significantly associated with, higher odds of unplanned re-
admission after adjusting for age and sex: being male; not
having private health insurance; lower social interaction
scores; severe physical functioning limitations; lower BMI;
having previous hospitalisation for: heart failure, other
major cardiovascular disease, renal disease or anemia;
current comorbidity; increasing hospital admissions and
total days in hospital in the previous 12 months; and if the
index admission was unplanned or not in a private hos-
pital. A higher odds of 30-day mortality was associated
with older age; severe physical functioning limitations;
lower BMI; current comorbidity; heart failure as a second-
ary diagnosis; increasing hospital admissions and total
days in hospital in the previous 12 months; and longer
length of index admission stay.
In the full multilevel model (Model 5, Table 2), the risk
of 30-day unplanned readmission was higher in males
(adjusted OR (aOR) = 1.18, 95% CI:1.00–1.37); those
with previous hospitalisation for major cardiovascular
disease (excl. heart failure) (aOR = 1.44, 1.08–1.91) or for
anaemia (aOR = 1.36, 1.14–1.63); and with increasing co-
morbidity (aOR for severe vs none = 1.26, 1.03–1.54); it
decreased with increasing social interaction scores (aOR
= 0.95, 0.91–0.99) and increasing BMI (e.g. aOR for
obese compared to normal weight = 0.77, 0.63–0.94).
Overall, hospital peer group was a significant variable in
the model (p = .03) with higher odds for public principal,
major city, district and community hospitals compared
with private hospitals (aOR = 1.33, 1.06–1.68).
In the full multilevel model (Model 5, Table 3), the
risk of 30-day mortality was higher in older people,
with the odds of post-discharge death increasing 2-
fold among those aged 75–84 (aOR = 2.04, 95% CI:
1.24–3.35) and three-fold in those aged 85 or older
(aOR = 3.23, 1.93–5.41), compared with those aged
45– < 75 years. It was also higher among those with
moderate (aOR = 1.42, 0.99–2.02) or severe comorbi-
dities (aOR = 2.68, 1.82–3.94), compared to none. The
risk of risk of 30-day mortality was lower in those
with heart failure as the primary rather than second-
ary diagnosis (aOR = 0.51, 0.36–0.72). The associations
between mortality and the two hospital-level variables
were not significant.
Characteristics significantly associated with the combined
unplanned re-admission/mortality outcome were similar to
those for unplanned readmissions models (Additional file 2:
Table S2 and Additional file 3: Table S3), reflecting the fact
that this combined measure was heavily weighted by
readmissions.
Sensitivity analyses showed the direction and size of
the associations between patient/hospital characteris-
tics 30-day unplanned readmissions were similar for
Table 1 Sample characteristics and proportionsa who were readmitted or died









Age (years, at index admission)
45– < 75 1303 26 20 1.8
75– < 85 2142 42 22 3.5
≥ 85 1629 32 20 5.5
Mean (SD) 80 (9.4) 80 (8.8) 84 (8.4)
Sex
Male 2927 58 22 4.0
Female 2147 42 19 3.2
Language other than English
Yes 559 11 21 3.4
No 4515 89 21 3.7
Marital status
Married 2864 56 20 3.6
Not married 2210 44 21 3.8
Region of residence
Major cities 2535 50 20 4.1
Regional 1566 31 21 3.5
Remote 973 19 22 2.9
Education
No school certificate 1134 23 21 3.8
School/Trade certificate, diploma 3211 66 22 3.5
Tertiary degree 524 11 18 5.0
Unknown 205
Household income (AUD)
< 20,000 1994 57 31 5.5
20,000–39,000 914 26 28 5.7
40,000–69,999 363 10 28 4.8
≥ 70,000 220 6.3 26 4.0
Unknown 1583
Private health insurance
Yes 2131 42 19 3.8
No 2943 58 22 3.6
Baseline health (self-reported)
Previous heart disease
Yes 2408 47 21 3.5
No 2666 53 20 3.8
Previous diabetes
Yes 1213 24 21 3.1
No 3861 76 21 3.9
Excellent memory
Yes 505 10 21 3.0
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Table 1 Sample characteristics and proportionsa who were readmitted or died (Continued)
No 4569 90 21 3.7
Physical functioning score
0– < 75 (severe) 2662 70 28 5.8
≥ 75 1127 30 25 2.7
Unknown 1285
Duke Social Support Index
Mean (SD) 8.7(1.6) 8.6 (1.6) 8.6 (1.7)
Psychological distress
Very low 3478 74 22 4.5
Low 770 16 24 2.2
Medium 312 6.6 27 4.5
High 140 3 25 3.1
Unknown 374
BMI
Underweight 128 2.8 27 7.9
Normal 1577 35 24 4.8
Overweight 1616 36 24 3.8
Obese 1191 26 20 2.3
Unknown 562
Smoking status
Current smoker 273 5.4 26 5.2
Ex-smoker 2384 47 21 3.4
Never smoker 2388 47 20 3.8
Unknown 29
Alcohol (drinks per week)
None 2230 46 22 3.8
1–14 drinks 2083 43 22 4.3
≥ 15 drinks 522 11 20 2.8
Unknown 239
Hospitalisation history (Admitted Patient Data Collection, 6 year prior to baseline)
Previous CVD
Yes 4669 92 21 3.6
No 405 8 15 4.4
Previous heart failure
Yes 1176 23 24 4.2
No 3898 77 20 3.5
Previous renal disease
Yes 564 11 26 3.9
No 4510 89 20 3.6
Previous anaemia
Yes 900 18 26 4.6
No 4174 82 20 3.5
Previous atrial fibrillation
Yes 1422 28 22 3.2
No 3652 72 20 3.8
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Table 1 Sample characteristics and proportionsa who were readmitted or died (Continued)
Previous dementia
Yes 73 1.4 18 6.9
No 5001 99 21 3.6
Hospitalisation history (Admitted Patient Data Collection, 12 months prior to index admission)
No. of admissions (last 12 months)
Mean (SD) 1.3 (2.9) 1.9 (5.0) 1.8 (3.4)
No. of hospital days (last 12 months)
Mean (SD) 7.0 (15) 9.2 (18) 11 (18)
Index admission characteristics
Primary diagnosis
Yes 1973 39 20 2.3
No 3101 61 21 4.6
Unplanned admission
Yes 4180 82 22 3.8
No 894 18 16 3.2
Length of stay (days)
1 450 8.9 18 2.7
2–6 1922 38 20 2.5
≥ 7 2702 53 21 4.7
Current comorbidity (Charlson Index)
Minor 2933 58 19 2.7
Moderate 1403 28 22 4.0
Severe 738 15 25 6.8
Length of stay (days)
Median (IQR) 7 (10) 7 (12) 12 (18)
Hospital characteristics
Hospital peer group
Principal referral 2493 49 22 3.4
Major city 537 11 20 5.0
District 606 12 21 4.1
Community 355 7 26 3.4
Private 900 18 17 3.7
Others 183 3.6 17 2.7
Heart failure service
Yes 1695 33 22 3.6
No 3379 67 20 3.7
Totals 5074 100 21 3.7
aProportions (%), or means and standard deviations [SD] or median and interquartile range (IQR) for continuous variables. Denominators for percentages are the
total known (i.e. non-missing/valid) values
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heart failure and broadly similar for those with a pri-
mary diagnosis only. Due to the small number of
events these analyses were not performed for 30-day
mortality.Discussion
People discharged from hospital with heart failure have
relatively poor outcomes. In this study, just over one in
ten patients died before discharge, and of those






















Fig. 2 Crude risks (%, with 95% confidence intervals) of 30-day
readmission and mortality by individual hospital, ranked from lowest
to highest, for the 157 hospitals with at least five index admissions
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sion and post-discharge mortality rates did vary across
hospitals, in our study this between-hospital variation
did not account for a significant proportion of the total
variation in outcomes once individual patient character-
istics were accounted for. A range of patient characteris-
tics were associated with a higher risk of unplanned
readmission, including being male, prior hospitalisation
for cardiovascular disease and for anemia, comorbiditiesat the time of admission, lower BMI and lower social
interaction scores. Similarly, risk of 30-day mortality was
associated with patient-level factors, in particular age
and comorbidity.
Heart failure is one of the most common underlying
medical conditions in patients readmitted to hospital
within a month of discharge [14, 33]. The risk of
unplanned readmission observed in this study was high
(21%), and very similar to that reported in a recent NSW
report based on initial admissions to all NSW public
hospitals (23%) [14]. They are comparable to those
reported in a similar study in the UK (18%) [11]. The risks
of mortality following heart failure admission and
discharge are broadly similar to those reported previously
in Australia [4, 5, 7, 17], and internationally [10–12],
allowing for differences in methodology, underlying
populations and/or changes over time in survival for
heart failure. That both sociodemographic factors and
clinical factors are independently associated with the
outcomes is a consistent finding in previous studies in
Australia [4, 5, 7, 17, 18], and elsewhere [10–12, 34, 35].
The considerable patient-level variation in outcomes
was not unexpected. More notable from this multilevel
study is that, although there was a considerable range in
the readmission and mortality risks across hospitals,
hospital-level variation accounted for little of the total
variation in outcomes. While these findings reflect the
variation within our sample and not necessarily the
actual variation in outcomes in NSW hospitals across
the whole of NSW, they are consistent with those of a
recent report on risk-adjusted hospital-level variation in
30-day return to acute care admissions in NSW. Al-
though employing different methodology and only in-
cluding index admissions to public hospitals, that
analysis revealed an overall high readmission rate but
few hospital outliers (7% with higher-than-expected
readmission rates) after risk-adjustment for patient age,
sex and hospital-recorded comorbidities [14]. They are
also consistent with the few other analyses that have
used multilevel modelling to quantify variation in
care, which found hospital-factors explained very little
of the variation in 30-day readmissions in the US [13]
and 30-day mortality in Sweden [12].
Taken together, the study findings indicate that the
issue of high readmission rates is a system-wide one,
rather than an issue confined to particular hospitals.
Moreover, considering the very high levels of morbidity
and frailty associated with heart failure, it is likely that
many of the factors influencing the risk of readmission
reside beyond the sphere of the hospital. Indeed, it could
be the case that the high readmission rates in heart
failure patients reflect a more general phenomenon, that
of frequent admissions among elderly people with mul-
tiple chronic conditions. Certainly, levels of comorbidity
Fig. 3 Time to unplanned readmission and death, by hospital type
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Fig. 4 Odds of 30-day unplanned readmission and unplanned readmission/mortality (logarithmic scale) for each hospital, ranked from lowest to
highest, with 95% confidence intervals
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among heart failure patients in this study and were
strongly associated with readmission. That comorbidity
is a key predictor of readmission is consistent with pre-
vious studies of heart failure patients [5, 7, 11, 14], and
other patient populations, such as those who have had a
stroke [36].
The study findings reinforce the importance of conside-
ring patient-level factors when interpreting standard
performance measures, such as short-term readmissions.
A recent US study has shown that if these factors are not
adequately accounted for, it can lead to perverse
outcomes, where higher quality hospitals that serve
vulnerable or medically complex patient populations may
be unfairly penalised for apparently poor performance
[37]. Moreover, readmission rates are only likely to be a
reasonable indicator of quality of care if there is consider-
able variation in the rates and if unmeasured case-mix
variations account for a small proportion of the inter-
hospital differences in these rates [38].
This is not to say that health systems are powerless to
decrease readmission rates. A recent Cochrane review of
25 randomised controlled trials including 5942 patients
found case management interventions, including nurse
monitoring of patients post-discharge by phone and
home visits, and multidisciplinary interventions that
promoted coordinated care of heart failure patients after
discharge, were associated with a reduction in both all-
cause and heart-failure-related readmissions [39]. In-
cluded in these reviews were two Australian trials, which
demonstrated a reduction in unplanned readmissions
and deaths in those receiving follow-up at home from a
cardiac nurse with multidisciplinary input [40, 41]. Fur-
ther Cochrane reviews concluded that telemonitoring
(remote monitoring of vital signs by cardiac specialist)
and structured telephone support interventions reduce
mortality and heart failure-related hospitalisations whencompared to usual care [42], and that exercise based-
rehabilitation programs for heart failure reduce the risk
of heart failure-specific hospitalisation [43]. Certain
features of heart failure disease management programs,
such as in-person communication, intensive patient
education and self-care supportive strategy, medication
optimization, and active involvement of a cardiac nurse
and cardiologist, have been identified as components in
successful programs that reduced hospital readmissions
and deaths related to heart failure and improved health
outcomes [44, 45]. Further, although prospective studies
are lacking, extensive expert opinion and consensus has
been published regarding the importance of multidiscip-
linary palliative care [46].
In this study, by linking hospital and death data to
baseline survey data we were able to model variation at
both the hospital and patient level, taking into account a
large range of patient sociodemographic and health
characteristics. However, there are several limitations
that should be borne in mind when interpreting the
results: (i) While participants were randomly sampled,
hospitals were not; (ii) Data on exposures were mostly
based on self-report; (iii) Several of the health measures
were baseline rather than contemporaneous with the
admission, and the elapsed-time between baseline health
status and the index admission varied across patients;
(iv) There was a lack of measured clinical data (e.g.
blood test and echocardiogram results); (v) There was
insufficient power to separately analyse index admissions
according to whether the diagnosis was primary or
secondary, readmissions exclusively for heart failure, and
shorter-term outcomes. It should also be noted that
despite the large overall sample size, power was limited
for some of the specific comparisons so negative null
findings should be interpreted with caution; (vi) While
we had information on the presence of a dedicated heart
failure service supplied by the NSW Heart Foundation,
Table 2 Multilevel model results for 30-day unplanned readmission: random effect measures and adjusted odds ratios (95%CIs) for
individual-level and hospital-level variables
Model 1 2 3 4 5
Random effects
Hospital variance 0.14 0.15 0.13 0.11 0.09
ICC 0.0205 0.0212 0.0172 0.0125 0.0074
P-value 0.12 0.12 0.17 0.24 0.34
MOR 1.43 1.44 1.41 1.37 1.32
PCV (%) −1.82 9.95 14.94 22.9
Fixed effects Odds ratios
Sociodemographic
Age (years, at index admission)
45– < 75 1.00 1.00 1.00 1.00
75– < 85 1.10 (0.93,1.31) 1.10 (0.93,1.31) 1.06 (0.89,1.27) 1.06 (0.89,1.27)
≥ 85 1.01 (0.84,1.21) 0.99 (0.82,1.19) 0.92 (0.75,1.13) 0.92 (0.75,1.13)
Sex
Male 1.19 (1.04,1.37) 1.23 (1.07,1.43) 1.17 (1.00,1.37) 1.18 (1.00,1.37)
Female 1.00 1.00 1.00 1.00
Marital status
Married 0.90 (0.77,1.04) 0.90 (0.78,1.05) 0.91 (0.78,1.05)
Not married 1.00 1.00 1.00
Region of residence
Major cities 1.00 1.00 1.00
Regional 1.01 (0.86,1.19) 1.03 (0.87,1.22) 1.03 (0.87,1.22)
Remote 1.08 (0.90,1.31) 1.13 (0.93,1.36) 1.04 (0.83,1.29)
Education
No school certificate 1.00 1.00 1.00
School/trade/certificate/diploma 1.11 (0.94,1.32) 1.13 (0.95,1.35) 1.14 (0.96,1.36)
Tertiary degree 0.89 (0.67,1.17) 0.89 (0.67,1.18) 0.91 (0.69,1.21)
Private health insurance
Yes 0.89 (0.77,1.03) 0.92 (0.80,1.07) 0.97 (0.83,1.14)
No 1.00 1.00 1.00
Baseline health (self-reported)
Duke Social Support Index 0.95 (0.91,0.99) 0.95 (0.91,0.99)
Body mass index
Underweight (15– < 18 kg/m2) 1.23 (0.80,1.89) 1.23 (0.80,1.89)
Normal (18– < 25 kg/m2) 1.00 1.00
Overweight (25– < 30 kg/m2) 0.98 (0.83,1.17) 0.98 (0.82,1.17)
Obese (>30–50 kg/m2) 0.78 (0.64,0.95) 0.77 (0.63,0.94)
Smoking status
Current smoker 1.00 1.00
Ex-smoker 0.76 (0.57,1.03) 0.78 (0.57,1.05)
Never smoker 0.76 (0.56,1.03) 0.77 (0.57,1.05)
Hospitalisation history (APDC, prior 6 years)
Previous CVD
Yes 1.41 (1.06,1.88) 1.44 (1.08,1.91)
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Table 2 Multilevel model results for 30-day unplanned readmission: random effect measures and adjusted odds ratios (95%CIs) for
individual-level and hospital-level variables (Continued)
No 1.00 1.00
Previous heart failure
Yes 1.12 (0.94,1.32) 1.11 (0.93,1.31)
No 1.00 1.00
Previous renal disease
Yes 1.12 (0.89,1.40) 1.11 (0.89,1.39)
No 1.00 1.00
Previous anaemia
Yes 1.36 (1.13,1.62) 1.36 (1.14,1.63)
No 1.00 1.00
Previous dementia




Yes 0.94 (0.81,1.08) 0.93 (0.80,1.07)
No 1.00 1.00
Current comorbidity (Charlson Index)
None 1.00 1.00
Mild-moderate 1.15 (0.98,1.35) 1.15 (0.98,1.35)












ICC intraclass correlation coefficient, MOR median odds ratio, PCV proportional change in variance
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and (vii) While the 45 and Up cohort are broadly represen-
tative of the Australian population in this age group, the co-
hort does not include people in residential care facilities,
and study participants are likely to be healthier and have
lower absolute hospitalisation rates than the general popula-
tion in this age group. However, given the near-complete
follow up of the cohort and other methodological consider-
ations, internal associations between patient, admission and
hospital characteristics are considered valid [47, 48].
A general, but important, limitation to consider when
using hospital data to report on heart failure is theaccuracy of the hospital coding for heart failure diag-
noses. A recent validation study using NSW APDC data
showed relatively high positive predictive values, of
between 85 and 92% [49], meaning that while we may
not have picked up every patient in the cohort who was
admitted with heart failure in the follow-up period, those
who we did include are likely to have had heart failure.
Finally, of particular interest to clinicians and policy
makers is whether the type of clinician providing care
(e.g. general specialist vs cardiologist) is associated with
patient outcomes, but this information is not available in
the hospital data. It would be also useful to have more
Table 3 Multilevel model results for 30-day mortality: random effect measures and adjusted odds ratios (95% CIs) for individual-level
and hospital-level variables
Model 1 2 3 4 5
Random effects
Hospital variance 0 0 0 0 0
ICC 0 0 0 0 0
Fixed effects Odds ratios
Sociodemographic
Age (years, at index admission)
45– < 75 1.00 1.00 1.00 1.00
75– < 85 1.99 (1.24,3.20) 1.97 (1.22,3.16) 2.07 (1.26,3.40) 2.04 (1.24,3.35)
≥ 85 3.33 (2.09,5.30) 3.23 (2.00,5.20) 3.30 (1.97,5.52) 3.23 (1.93,5.41)
Sex
Male 1.36 (1.00,1.84) 1.34 (0.96,1.85) 1.36 (0.96,1.93) 1.36 (0.96,1.93)
Female 1.00 1.00 1.00 1.00
Marital status
Married 1.02 (0.74,1.40) 1.06 (0.77,1.47) 1.06 (0.77,1.47)
Not married 1.00 1.00 1.00
Region of residence
Major cities 1.00 1.00 1.00
Regional 1.01 (0.72,1.41) 1.06 (0.75,1.50) 1.03 (0.72,1.46)
Remote 0.85 (0.55,1.31) 0.90 (0.58,1.40) 0.83 (0.51,1.38)
Education
No school certificate 1.00 1.00 1.00
School/trade/certificate/diploma 0.90 (0.62,1.31) 0.91 (0.62,1.32) 0.91 (0.62,1.32)
Tertiary degree 1.18 (0.69,2.01) 1.15 (0.67,1.98) 1.16 (0.67,1.99)
Private health insurance
Yes 1.05 (0.77,1.43) 1.10 (0.80,1.51) 1.12 (0.80,1.56)
No 1.00 1.00 1.00
Baseline health (self-reported)
Duke Social Support Index 0.97 (0.88,1.07) 0.97 (0.88,1.07)
BMI
Underweight 1.68 (0.80,3.52) 1.63 (0.77,3.42)
Normal 1.00 1.00
Overweight 0.90 (0.62,1.30) 0.90 (0.62,1.31)
Obese 0.62 (0.38,1.02) 0.61 (0.37,1.01)
Smoking status
Current smoker 1.00 1.00
Ex-smoker 0.50 (0.27,0.94) 0.49 (0.27,0.92)
Never smoker 0.58 (0.31,1.09) 0.57 (0.31,1.07)
Hospitalisation history (APDC, prior 6 years)
Previous CVD
Yes 0.73 (0.43,1.22) 0.74 (0.44,1.24)
No 1.00 1.00
Previous heart failure
Yes 1.23 (0.85,1.77) 1.22 (0.84,1.76)
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Table 3 Multilevel model results for 30-day mortality: random effect measures and adjusted odds ratios (95% CIs) for individual-level
and hospital-level variables (Continued)
No 1.00 1.00
Previous renal disease
Yes 0.73 (0.44,1.21) 0.73 (0.44,1.21)
No 1.00 1.00
Previous anaemia
Yes 1.17 (0.80,1.72) 1.18 (0.81,1.72)
No 1.00 1.00
Previous dementia




Yes 0.52 (0.36,0.73) 0.51 (0.36,0.72)
No 1.00 1.00
Current comorbidity (Charlson Index)
None 1.00 1.00
Mild-moderate 1.42 (0.99,2.02) 1.42 (0.99,2.02)












ICC intraclass correlation coefficient
Korda et al. BMC Health Services Research  (2017) 17:220 Page 16 of 18detailed information on hospital characteristics and
post-discharge out-of-hospital care.
Conclusions
Findings suggest that the issue of high rates of readmis-
sion and mortality in people with heart failure apply more
to the system as a whole than to particular hospitals. That
comorbidity is a major predictor of both readmission and
mortality highlights the need for caution in penalising
hospitals for treating complex patients. They also point to
the need for patient-centred strategies to identify those at
high risk of readmission and to optimise heart failure
management, including appropriate discharge planning
and accessible community services. The findings also
reinforce the importance of enhanced preventative
strategies as the population ages, risk factor burdenincreases and survival rates from acute coronary syn-
dromes continue to improve.
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